Medication overuse headaches – what is new?

  title={Medication overuse headaches – what is new?},
  author={Guenther Fritsche and Hans Christoph Diener},
  journal={Expert Opinion on Drug Safety},
  pages={331 - 338}
Patients suffering from frequent migraine attacks or chronic tension-type headache are at risk of developing drug-induced headache (now called ‘medication overuse headache’ [MOH]) as described by the new classification of the International Headache Society. This headache entity is caused by frequent use of antiheadache compounds (non-opioid analgesics, ergot alkaloids, 5-HT agonists, combined preparations with caffeine or codeine) for more than 15 days/month. Most patients, however, use the… 

Medication-overuse headache in patients with cluster headache

Medication-overuse headache is a previously underrecognized and treatable problem associated with cluster headache (CH).

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study

Eptinezumab use in patients with CM was associated with greater decreases in days with headache with AHM overall and with triptans in particular, and the magnitude of effect was greater in the subgroup of CM patients with MOH and ≥ 50% response.


Migraine may bring a suffering phase in an individual's schedule yet it can be handled with the familiarity of some self-care remedies and by making simple modifications in the routine lifestyle, which may facilitate to pave the clear way to recovery and make things easier for migraine management.

Efficacy of fixed combinations of acetylsalicyclic acid, acetaminophen and caffeine in the treatment of idiopathic headache: a review

In the treatment of migraine and tension‐type headache, the combination of ASA, acetaminophen, and caffeine has been shown to be more efficacious and superior to monotherapy with the single substances of the combination.

Advice Alone Vs. Structured Detoxification Programmes for Medication Overuse Headache: A Prospective, Randomized, Open-Label Trial in Transformed Migraine Patients With Low Medical Needs

In patients with migraine plus MOH and low medical needs, effective drug withdrawal may be obtained through the imparting of advice alone.

Diagnosis and management of headache.

  • J. LewisE. Frohman
  • Medicine, Psychology
    Obstetrics and gynecology clinics of North America
  • 2001

A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain.

Chronic pain rehabilitation in chronic headache disorders

Pain rehabilitation is described, outcome data for chronic pain patients treated in this setting is reviewed, and the unique applicability of this treatment approach for patients with chronic headache is described.

Chronic pain rehabilitation in chronic headache disorders

Pain rehabilitation is described, outcome data for chronic pain patients treated in this setting is reviewed, and the unique applicability of this treatment approach for patients with chronic headache is described.

Orofacial pain--Part I: Assessment and management of musculoskeletal and neuropathic causes.

The salient clinical features and the therapeutic approaches for the various subtypes of musculoskeletal and neuropathic pain are presented.



Drug-Induced Headache: Long-Term Follow-Up of Withdrawal Therapy and Persistence of Drug Misuse

The data show a higher relapse rate than previously assumed and that certain substance groups bear aHigher relapse risk.

Prednisone as Initial Treatment of Analgesic-Induced Daily Headache

It is demonstrated that it is possible to detoxify patients suffering from rebound headaches, using oral prednisone during the first days of withdrawal, in an out-patient setting.

Features of medication overuse headache following overuse of different acute headache drugs

Although patients overusing ergots and analgesics typically had a daily tension-type headache, patients with triptan-induced MOH were more likely to describe a (daily) migrainelike headache or an increase in migraine frequency.

Analgesic-induced chronic headache: long-term results of withdrawal therapy

Migraine prophylaxis through beta-blocking agents and calcium channel antagonists was more efficient after drug-withdrawal therapy and patients who originally suffered from migraine, superimposed on the daily headache, also experienced a significant improvement in the frequency of the migraines and their intensity.

Drug overuse and rebound headache

The recent development of acute headache medications, especially the triptans, has provided increased migraine relief; however, the incidence of triptan-overuse headache has also increased.

Headaches Associated With Chronic Use of Analgesics: A Therapeutic Approach

It is shown that within the group of relapsing patients the outpatients relapsed to analgesic intake more than the day hospital‐treated patients (P<0.001), and there were no differences in reduction of mean values of the Headache Index or daily drug intake with respect to the two treatments.

Drug-Induced Headache: Long-Term Results of Stationary Versus Ambulatory Withdrawal Therapy

The data suggest that neither the method of withdrawal therapy nor the kind of analgesic and other antimigraine drugs has a major impact on the long-term result after successful withdrawal therapy in drug-induced headache.

Clinical Manifestations of Excessive Use of Analgesic Medication

Physicians experienced in the treatment of migraine and other forms of headache are nowadays well aware that the daily intake of antipyretic or anti-inflammatory analgesics or combinations with

Drug Abuse in Chronic Headache: A Clinico-Epidemiologic Study

The investigation suggests that all instant-relief drugs can sustain and possibly initiate a chronic headache.